Yu-Hsin Lin - 21 Apr 2026 Form 4 Insider Report for BELITE BIO, INC (BLTE)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: BLTE
Reported as of: 21 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Apr 2026, 16:23:00 UTC
Prior SEC filing: 13 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Yu-Hsin Lin

Key filing fact

Yu-Hsin Lin filed Form 4 for BELITE BIO, INC (BLTE) on 23 Apr 2026.

Key facts

This page summarizes Yu-Hsin Lin's Form 4 filing for BELITE BIO, INC (BLTE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Apr 2026, 16:23.

Change

Previous filing in this sequence was filed on 13 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001965964 Primary reporting owner

Lin Yu-Hsin

Relationship: Chief Executive Officer, Director
Address: 12750 HIGH BLUFF DRIVE, SUITE 475, SAN DIEGO
Signature: /s/ Yu-Hsin Lin
Signature date: 23 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLTE transaction

Ordinary Share

Other

Transaction value
Shares: +10,000
Change %: +5.8%
Price: $0.000000^*
Shares after: 182,949
Date: 21 Apr 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On September 15, 2025, the reporting person was granted an award of restricted stock units ("RSUs") which shall vest upon satisfaction of certain performance criteria. Such performance criteria was met on 04/21/2026, resulting in vesting of the RSUs as to 10,000 ordinary shares.